NICE recommends natalizumab, including a lower-cost biosimilar, as a new MS treatment for adults with highly active relapsing-remitting multiple sclerosis, expanding options for thousands of patients ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

Summary: A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis. Researchers discovered that a high ...

A study from Sweden’s Uppsala University discovered a link between microplastics and multiple sclerosis (MS). The research, published in the journal Environmental International, discovered that ...

Yes, “KPop Demon Hunters” makes the list. But that was just one of the standouts in a great year. By Maya Phillips My list of favorite animation this year includes time-traveling rainbow people, ...

Exposure to "forever chemicals" (PFAS) and PCB metabolites increases multiple sclerosis (MS) risk Highest levels of PFAS and PCBs doubled the odds of MS diagnosis Complex interaction between genetic ...